- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Experts see a future in EBV-related disease vaccination
About 9 of every 10 people are believed to be infected with Epstein-Barr Virus (EBV). When infected as juveniles, the virus is associated with several diseases, ranging from mononucleosis to various cancers and more.
According to an article written collectively by directors from the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), the National Cancer Institute (NCI) and other experts, a vaccine that could prevent EBV infection may not be possible with current understanding of the virus, but it might be possible to develop an EBV vaccine that could prevent diseases associated with EBV infection, including forms of lymphoma including Hodgkins lymphoma as well as Burkitt's lymphoma, the latter among the most aggressive of all cancers.
The article outlined the direction future research should take in this regard, and it includes looking for bio-markers that would help doctors predict EBV-related cancer development and widespread collaboration among experts in government, industry, and academia to develop that EBV vaccine.